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Abstract
This article describes a Digital Health Framework (DHF), benefitting from the lessons learnt during the three-year life
span of the FP7 Synergy-COPD project. The DHF aims to embrace the emerging requirements - data and tools - of
applying systems medicine into healthcare with a three-tier strategy articulating formal healthcare, informal care and
biomedical research. Accordingly, it has been constructed based on three key building blocks, namely, novel
integrated care services with the support of information and communication technologies, a personal health folder
(PHF) and a biomedical research environment (DHF-research). Details on the functional requirements and necessary
components of the DHF-research are extensively presented. Finally, the specifics of the building blocks strategy for
deployment of the DHF, as well as the steps toward adoption are analyzed. The proposed architectural solutions and
implementation steps constitute a pivotal strategy to foster and enable 4P medicine (Predictive, Preventive,
Personalized and Participatory) in practice and should provide a head start to any community and institution
currently considering to implement a biomedical research platform.
Background
The seminal purpose of the systems medicine design [1]
conceived for the Synergy-COPD project [2] was to gen-
erate knowledge on underlying mechanisms explaining
heterogeneities observed in chronic obstructive pulmon-
ary disease (COPD) patients. The ultimate aim of the
project was to use such knowledge to refine patient’s
stratification, prognosis and treatment response, which
then should lead to efficient preventive strategies aiming
at modulating disease progress while reducing the bur-
den of COPD on healthcare.
It is well accepted that predictive medicine is opening
entirely new and fascinating scenarios for the interplay
between clinical practice and biomedical research. How-
ever, at the same time, it is generating novel require-
ments with impact on adoption. Firstly, the need for
multilevel integration of heterogeneous patient informa-
tion (Figure 1), namely: socio-economical, life-style,
behavioural, clinical, physiological, cellular and “omics”
data [3] and their use for the design of a personalised
digital patient from virtual physiological models.
Secondly, the need to extend current trends on open
data from the biomedical community [4] to the clinical
practice and the whole society, by engaging citizens and
solving privacy and regulatory constraints, Finally, the
need for highly applicable user-profiled functionalities
for data management and knowledge generation.
Accordingly, innovative and robust Information and
Communication Technologies (ICT) will be needed as
supporting tools to overcome well identified current
functional limitations [5].
The concept of Digital Health Framework (DHF)
(Figure 2) emerged from the Synergy-COPD project to
foster adoption of predictive medicine. The DHF consists
of the articulation of open and modular ICT components
supporting organizational interoperability, and appropriate
functionalities, among three main areas, namely: i) infor-
mal care, ii) formal care, and, iii) biomedical research.
Briefly, informal care includes any aspect with impact on
health (e.g. life style, environmental and behavioural
aspects, etc.) occurring in the community, whereas formal
care refers to any interaction with health professionals at
different levels of the healthcare system. Biomedical
research refers to all research levels from bench to clinical
and to public health. In our hands, to materialize such an
ambitious vision, a building block approach is considered
* Correspondence: iscano@clinic.ub.es
1IDIBAPS-Hospital Clínic, CIBERES, Universitat de Barcelona, 08036, Barcelona,
Catalunya, Spain
Full list of author information is available at the end of the article
Cano et al. Journal of Translational Medicine 2014, 12(Suppl 2):S10
http://www.translational-medicine.com/content/12/S2/S10
© 2014 Cano et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
necessary. Moreover, the progress from the initial proof-
of-concept to pilot implementation and to extensive
deployment shall be planned following a stepwise strategy.
The first building-block was the design and initial
deployment of an open source Integrated Care Shared
Knowledge Platform supporting Integrated Care Services
(ICS) for chronic patients, initiated at the EU project
NEXES [6]. During the life span of NEXES, a Personal
Health Folder (PHF) was successfully piloted [7], as a
supporting tool to achieve long-term sustainability of
training-induced effects and promote active life styles in
COPD patients. The PHF constitutes the second building
block currently being implemented in a health district
(Barcelona-Esquerra, 540.000 inhabitants) in Barcelona as
a tool to integrate informal and formal care in commu-
nity-based ICS for frail chronic patients. Moreover, the
Figure 1 The holistic approach intrinsic to system medicine of non-communicable diseases (NCDs) prompts the need for multilevel
integration of heterogeneous patient information generated by different data sources, namely: environmental, clinical and biological
data.
Figure 2 The concept of Digital Health Framework covers the different areas wherein information can be obtained and actions are
taken: i) informal care, ii) formal care, and, iii) biomedical research. In this scenario, a personal health folder incorporating patient decision
support systems (PDSS) might facilitate the incorporation of data coming from informal care into formal healthcare. In addition, biomedical research,
referring to all research levels from clinical to basic research, should be shaped to provide user-profiled functionalities such that research professionals
with different profiles can make use of clinical and biomedical knowledge from formal healthcare and heterogeneous biomedical research data
sources, ultimately leading to the generation of novel rules that should feed in-place clinical decision support systems (CDSS).
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Clinical Decision Support Systems (CDSS) generated
during the Synergy-COPD lifetime [8] has been integrated
into an ICT platform supporting ICS. Consequently, the
interplay between the first two building blocks (informal
and formal care) is operational in a controlled deployment
scenario and is currently evolving toward maturity. We
shall keep in mind, however, that active citizens/patients
together with a prepared multidisciplinary health work-
force will be the real key drivers of the transition from cur-
rent healthcare practice to full deployment of predictive
medicine for chronic patients.
The current report focuses on the third building block
of the DHF, tackling biomedical research (DHF-research).
The manuscript analyses architectural design, functional-
ities and implementation strategies of interoperability
between healthcare and biomedical research.
Progress from this paper
We report on the key elements needed for the design of
the DHF-research, showing interoperability with the open
Integrated Care Shared Knowledge Platform already
operational in the Barcelona-Esquerra health district.
From the methodological standpoint, the manuscript per-
forms a systematic description of the DHF-research
architecture and functionalities based on the lessons
learnt in Synergy-COPD indicating the contributions
beyond the current state of the art. The expected out-
come of the manuscript is to generate a proof-of-concept
of the DHF-research component as well as to propose
strategies for its assessment and future implementation.
The DHF principles: lessons learned from the Synergy-
COPD project
Main actors of the DHF
Table 1 describes the profiles of typical actors in the DHF:
biomedical research actors (Clinical and Basic scientists),
healthcare actors (specialized and primary care), and three
patient profiles corresponding to three possible COPD
status (moderate COPD, complex COPD and COPD with
comorbid conditions). Furthermore, the three patient pro-
files represent different levels of stratification and persona-
lized therapeutic strategies guided by CDSS. The CDSS is
embedded into an Integrated Care Shared Knowledge
Platform which, in turn, make summary PHF information
available to the clinician. In all three cases, the PHF-PDSS
facilitates bidirectional interactions between patients and
health professionals toward improving adherence to treat-
ment, patient empowerment of his/her health status and
interfacing with informal and social care [7]. Finally, the
professionals with research roles will be using the biome-
dical research platform (DHF-research), which has as
data sources clinical information (through the Integrated
Care Shared Knowledge Platform) as well as heteroge-
neous public and corporate sources of biomedical
research data and the necessary tools to manage and pro-
cess these data.
Overall, an integrated care scenario provides support to
organizational and technical interoperability between
informal care and healthcare systems, which in turn feeds
the DHF-research with controlled and standardized clini-
cal information for off-line research purposes. As an
example, the Synergy-COPD project identified that oxida-
tive stress may play a central role in COPD-complex and
COPD-co-morb such that research professionals (with
translational clinical and basic background) cooperate
using the DHF-research to further explore other poorly
known mechanisms and to generate combined biomarkers
to assess novel therapeutic strategies in the clinical sce-
nario. The DHF-research should be shaped to provide
user-profiled functionalities such that research profes-
sionals with different profiles can make use of it, ultimately
leading to the generation of novel rules that should feed
in-place CDSS and PDSS.
Functional principles
Based on the storyboard presented in the previous section
we identified three key functional principles for the correct
adoption of the DHF-research, namely: (i) data standardiza-
tion strategies and open data policies, toward technical,
syntactic and semantic interoperability between clinical
data systems and biomedical research platforms, taking into
account the privacy challenges of biomedical data sharing;
(ii) profile-specific visual data mining functionalities
Table 1 Description of Actors and Roles in the Digital
Health Framework













Primary Care Clinical Primary Care CDSS
Specialized Care Clinical Secondary
Care
CDSS
Clinical Scientist Research Academic DHF-
research
Basic Scientist Research Academic DHF-
research
COPD-moderate, patient with moderate functional impairment and low
activity disease; COPD-complex, patient with moderate to severe functional
impairment with active disease both at pulmonary and systemic levels
(skeletal muscle dysfunction/wasting); COPD-co-morb, patient with moderate
functional impairment, high activity disease and co-morbid conditions
(metabolic syndrome and cardiac failure);PC, Primary Care professionals
(doctor & nurse); Specialized Care, Specialized Care (doctor&nurse); Clinical
Scientist, Translational research with clinical focus; Basic Scientist, Translational
research with focus on basic sciences; PHF-PDSS, personal health folder
including Patient Decision Support Systems; CDSS, Clinical Decision Support
Systems; DHF-research, Digital Health Framework-Biomedical research
platform.
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covering the disparate needs and backgrounds of the DHF
actors; and finally (iii) profile-specific environments sup-
porting multi-scale predictive modelling and several forms
of complex data analytics.
Architectural principles
The DHF-research architecture considers specific com-
ponents to cover the need for organizational interoper-
ability between research professionals working together
over the same hypothesis and study design, as identified
during the execution of Synergy-COPD. Moreover, gen-
eral architectural principles are considered toward an
open source solution with a rich set of functionalities
empowering knowledge sharing, data querying and data
analytics by means of a distributed, multi-layer, service
oriented and ontology-driven architecture.
Ethical and legal issues
The evolving European legislation on health data trans-
fer and security [9-12] was analysed and taken into
account for the design of each of the three components
of the DHF (Figure 2) and facilitate the empowerment
of patients to open their personal clinical data and
derived studies to the scientific community.
Deployment strategies and assessment
The three building blocks of the DHF (Figure 2) have
independent deployment strategies all of them with a
stepwise approach. The DHF-research is in an early
phase of the design of the proof-of-concept generated
from the lessons learnt in the Synergy-COPD project.
Steps for a proper validation and identification of strate-
gies for deployment were defined in the study.
Description of the components and functionalities of the
DHF-research
The Synergy-COPD project prompted the identification of
three pivotal layers of the DHF-research, depicted in
Figure 3, to support the following research functionalities:
i) a semi-automatic data mapping, consistency, and stan-
dardization layer; ii) an integrative knowledge manage-
ment layer to gather and integrate clinical and biomedical
knowledge coming from various healthcare electronic
health systems and research information systems, as well
as public databases; and, iii) to build on top of the knowl-
edge management layer, a qualitative and quantitative data
exploitation layer with profile-specific visual data mining
user-profiled interfaces.
In the standardization layer displayed at the bottom of
Figure 3, mapping, consistency, and standardization of clini-
cal data will primarily rely on in-place health information
exchange (HIE) infrastructures, where standard terminology
(e.g. SNOMED-CT, SERAM, SEMN, LOINC, etc.), message
encoding (e.g. HL7 2.x / 3.x, MLHIM, openEHR, ISO
13606, etc.), message routing and Security (e.g. IPSec, Audit
trail, Node authentication, etc.) will be used. Moreover, the
HIE infrastructure will provide the required technical and
syntactic interoperability to support the information
exchange requirements inherent to the logics of integrated
care processes. Specifically, the DHF considers the use of an
open source Integrated Care Shared Knowledge Platform
designed to support the execution of ICS, which allows to
normalize the process logics of ICS to a common legacy
schema or data model. Similarly, standardization of biome-
dical research data and metadata (ISA-Tab [13], MIAME,
etc.) is a required task before its connection to the knowl-
edge management layer. This step will not be required for
those public biomedical research data sources already stan-
dardized (e.g. Ensembl, Uniprot and KEGG). The ICS
Knowledge Platform also considers integration with perso-
nal health folders, so that valuable data generated outside
the boundaries of formal healthcare institutions, such as
self-management questionnaires and applications, genomic
and biomedical data, will be gathered and effectively incor-
porated into the formal care arena in the context of an inte-
grated care service prescribing interactions with patients via
the personal health folder. Ultimately, data normalization
and curation is the responsibility of each data source before
interfacing with the knowledge management system. How-
ever, each data source should agree with the knowledge
management layer how to effectively ensure data normaliza-
tion. Finally, each data source should make use of their
specific front-end interfacing to effectively support the
normalization and curation of already existing data, or to
support the normalization of the data right at the data
source (e.g. questionnaires, lab tests, etc.).
Once all input data sources are properly encoded to a
reduced set of common vocabularies and metadata sche-
mas, and the exploitation rights granted, a knowledge
management layer (as depicted in the middle of Figure 3)
should allow the investigator to first integrate [14] and
then to manage all of the above DHF-research informa-
tion assets with easy to use and agile knowledge manage-
ment graphical user web interfaces. The proprietary
knowledge management solution assessed during the
execution of the Synergy-COPD project [15] was based
on the concept of knowledge as network by abstracting
commonly used concepts and knowledge into objects
and their relations. In addition, it bridged multiple
sources and scales of knowledge and various determinis-
tic and probabilistic models with a systems biology
approach. Structuring explicit and implicit knowledge
into these formal concepts enabled the use of existing
well-defined vocabularies (e.g. GO, ICD10) and standards
(e.g. SBML, HL7) to couple true semantic integration (i.e.
the mapping of equivalent meaning and objects) across
all information types relevant in translational research
with a flexible and extensible data model, ensuring
robustness against structural changes in services and
data, transparent usage, and low set-up and maintenance
requirements. This knowledge management layer may
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also facilitate non-technological aspects of human and
cultural dimensions to effectively enable information and
knowledge sharing.
Finally, this leads to the exploitation layer as displayed
in the upper side of Figure 3 wherein potential use of
profile-specific visual data exploitation portals are con-
sidered to support agile data querying at first and facili-
tating posterior data analytics. The latter will include a
simulation environment capable of facilitating the user-
friendly simulation of multi-scale predictive models,
from common descriptive analytics to complex model-
ling approaches.
The user-profiled portals ought to be primarily used by
the two research actors of the DHF, the clinical and the
basic scientist (Table 1), allowing them, for example, to
mine registered information to gain insight into mechan-
isms leading from health to disease transition and to
study disease natural evolution, as well as interactions
among diseases. Initial search, retrieval and R-plugin
based data mining methods integrated into the Synergy-
COPD knowledge base [16] enabled the retrieval of dis-
ease or case specific sub-networks by expert users but
the validation showed that to enable application by clini-
cal researchers a simplification of the user interface was
required. To this end, the DHF-research considers the
use of agile data querying interfaces such as those pow-
ered by the BioMart [17,18] platform, used in the inter-
national cancer genome consortium (ICGC) Data Portal
[19]. However, connectors to the R programming lan-
guage should be available to accommodate for the needs
of basic researchers having a bioinformatics profile. In
addition, standard data analytic tools commonly used by
clinical researchers should be made available within the
exploitation layer. Moreover, such user-profiled portals
may include links to new tools such as the Synergy-
COPD multi-scale simulation environment [20], designed
Figure 3 DHF-research components and functionalities include semi-automatic data standardization approaches, data integration and
knowledge management, profile-specific visual data mining portals and user-profiled simulation environments (see text for further details).
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to enable the explorative execution of computational
models. Ultimately, this data exploitation process should
enable the translation of novel biomedical research out-
comes into real clinical practice via generation of rules
feeding novel CDSS. The latter (CDSS) should be
embedded into novel clinical processes defined in terms
of integrated care services, so closing the DHF continu-
ous improvement circle.
Contributions of the DHF-research beyond the current
state of the art
We performed a thorough review of available ICT plat-
forms that have been designed to support biomedical
research with a systems approach [21-25]. Unfortunately,
the reported information is fragmented and often insuffi-
cient to display a complete picture of each translational
research platform. We review here the main characteristics
of five state of the art initiatives considering the above
DHF-research functional layers, namely: data standardiza-
tion, knowledge management and data exploitation.
Standardization layer - All five systems [21-26] sup-
port integration of data encoded using standard ter-
minologies for clinical data entities (e.g. ICD9-CM,
SNOMED, LOINC, etc.), but such an extensive use of
standard terminologies is more difficult to accomplish in
the context of basic biomedical research data adding
extra efforts for the appropriate integration of data from
different omics levels (e.g. Ensemble database, based on
the BioMart project [17,18]).
A completely differentiating issue is the potential to
interoperate with in-place clinical information, as such a
functionality was only reported in STRIDE [21] that
showed interoperability through a Health Information
Exchange (HIE) platform via HL7 RIM messaging. It is of
note that none of the five systems analysed [21-25] showed
potential to interoperate with chronic care clinical infor-
mation as described above.
Knowledge management layer - All platforms [21-25]
have reported the use of multiple standard terminologies
for semantic integration of data from various sources, but
none of them describes a complete set of tools for infer-
ence analyses as reported in detail in [16]. There is also a
clear need to extend the Open Access framework into the
clinical and personal perspective.
Exploitation layer - All state of the art translational
research platforms offer comprehensive sets of data
mining and exploitation tools through unique user por-
tals targeting all types of researchers roles, which neces-
sarily limits acceptability and usability of the system that
otherwise could greatly improve with a user-profiled
approach. Moreover, current data exploration and data
querying tools (such as the i2b2 [23] query tool) show
potential to evolve toward more dynamic and agile data
exploration capabilities.
The review clearly identified the need for expanding
the spectrum of users that should be achievable through
a proper user-profiled orientation aiming at enhancing
current user interfaces. An open source architecture with
a service-oriented approach seems most adequate to
build-up innovative business models allowing the contin-
uous developments of enhanced functionalities based on
sustainable costs-benefit ratios. Open Data schemas for
all kind of data that the DHF integrates, the active role of
patients and their empowerment to grant access to their
own data, become crucial.
Discussion
Contributions to a biomedical research scenario for
predictive medicine
The convergence of two major driving forces: i) current
re-shaping of health systems seeking efficiencies
through the alignment with the needs generated by
chronic conditions, as discussed in detail in [1,27]),
and, ii) rapidly evolving perspectives of biomedical
knowledge [28] is fostering the transition towards a
mature 4P medicine scenario for chronic patients.
To the best of our knowledge, Synergy-COPD has
provided one of the first relevant technological and
biomedical contributions to this transition, using
COPD and the analysis of co-morbidities as a use case.
But most importantly, the project has identified impor-
tant gaps, crucial unmet needs and strategic proposals
that should help to consolidate the emerging scenario,
specifically in the COPD case and in general to other
disease areas. In this context, the conceptualization of
the components of the DHF-research, as well as the
proposals for its effective deployment together with the
articulation of biomedical research with both formal
and informal care, constitute one of the most signifi-
cant outcomes of the project.
The deployment of the concepts described in the cur-
rent report should allow an efficient bidirectional articu-
lation between biomedical research and both healthcare
and environmental factors with impact on disease devel-
opment and activity. By doing so, we can reasonably
speculate that preventive strategies modulating the tran-
sition from health to disease, as well as disease progress,
will be effectively implemented and adopted as part of
the future conventional health promotion and healthcare
scenario. Finally, it is expected that such future health-
care scenario may influence business innovation in phar-
macological industry and healthcare business models by
overcoming current fragmentation among informal care,
healthcare and biomedical research, which shall have a
high impact in shortening time to market for both drug
development and drug repositioning. It may also help to
foster novel synergies between pharmacological and
non-pharmacological therapies.
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Challenges for deployment of the DHF
The complexities of the deployment of the three-tier
DHF, involving multiple interoperability levels (e.g. tech-
nological, organizational-cultural, etc.) and actors, are
acknowledged.
Informal Care - Previous experiences using Personal
Health Systems [29] in general and with the PHF-PDSS
[7] in particular have shown the potential of this tool
serving three main purposes: i) empowering citizens and
patients toward an active role in disease prevention and
management, ii) favouring collection of structured infor-
mation on environmental, sociological and behavioural
factors influencing health status, as well as informal care
interventions, and, iii) contributing to organizational
interoperability at health system level. However, practi-
calities limiting the extensive deployment and adoption
of the PHF-PDSS have not been fully solved yet, but all
of them seem actionable. These limiting factors encom-
pass a wide spectrum of aspects, namely: technological
approaches securing subject identification and data priv-
acy, legal classification of the supporting systems as
medical or non-medical devices, design of user-friendly
interfaces and business models generating incentives for
adoption, and also the interfacing between PHF-PDSS
(informal care) and electronic health records (formal
healthcare). It is of note, however, that all the above
limiting factors are being addressed in several EU
regions because the PHF-PDSS is becoming a pivotal
component in the reshaping of the health system to face
the challenge of chronic conditions.
Formal care - There is increasing evidence that
deployment of articulated integrated care services (ICS)
covering the entire spectrum of patient severity is a
good strategy to enhance health outcomes with cost
containment [30]. Different open ICT-platforms and
strategies have been proposed to efficiently support the
extensive deployment of ICS [30]. Implicit with those
strategies are the integration of information collected
through the PHF-PDSS (articulation with informal care)
and clinical data normalization aiming at facilitating
information sharing across healthcare tiers and among
territories. Figure 3 in the current manuscript proposes
such open ICT-platforms as a realistic option to inte-
grate citizen information generated in either an informal
or a formal care scenario, into biomedical research plat-
forms (DHF-research). We acknowledge, however, that
extensive deployment of those systems is still under
development. A complementary approach to the propo-
sal indicated in Figure 3 to facilitate short-term data
integration into DHF-research could be the setting of
highly curated clinical datasets specifically used for
research purposes.
Biomedical research - The deployment of DHF-
research proposals displayed in Figure 3 require stepwise
implementation strategies wherein two key aspects
clearly emerge as main short-term priorities. Firstly, ICT
developments aiming at generating user-friendly portals
for clinicians devoted to translational research. A second
element is the convergence of on-going developments in
the area of knowledge management giving particular
priority to the assessment of inter-molecular (proteins,
genes, or metabolites) interactions (physical or func-
tional), transcriptional regulation and gene-disease
association, that should foster the bridging between
omics-generated knowledge and the clinical arena.
Finally yet importantly, progresses in this area will be
strongly associated to strategies fostering convergence of
on-going ICT developments including both open and
proprietary approaches. Finally, a relevant area is the
design of innovative business models providing sustain-
ability of biomedical research platforms beyond specific
research and/or infrastructure projects that triggered the
initial settings.
For all three DHF tiers, both legal and ethical aspects
ensuring privacy and security of data transfer and man-
agement delineate a crucial area to be properly
handled. Both data anonymization and encryption stra-
tegies have experienced a significant progress contri-
buting to partially solving the problem. However, they
show clear limitations in areas such as the management
of genetic information wherein data anonymization is a
challenge. In addition, the use of data for purposes
other than the original data collection aims may gener-
ate limitations and activating communities of data
donators for scientific purposes with a wider view than
current practices is required. Clearly, evolving both
legal frames and citizen cultural attitudes will be cru-
cial to achieve a balance between social acceptance of
anonymized data sharing together with reasonable
levels of security and privacy of data transfer and
management.
Developments beyond the project lifetime
We fully acknowledge that the current manuscript only
displays basic lessons learnt during the Synergy-COPD
project life span. Next immediate steps to be taken
before the end of the project are twofold. First, to
establish a focus group, including all actors, for the
qualitative assessment of the current DHF proposal.
The aim of the focus group should be to perform a
qualitative assessment of the DHF fitness to transfer
the biomedical research use case of Synergy-COPD to
more general clinical research needs. Second, to gener-
ate structured interactions with well-known interna-
tional experts in the three tiers of the DHF to
prioritize specific steps of the deployment strategy,
and, to plan collaborative interactions with selected
on-going projects addressing similar aims.
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Conclusions
The DHF is presented as a comprehensive and coherent
ICT strategy supporting emerging requirements of
applied systems medicine with novel interactions
between informal care, formal healthcare and biomedical
research. The current manuscript proposed ICT solu-
tions for the three DHF tiers, extending more its biome-
dical research component, and stepwise strategies for
effective deployment of the concept that should foster
implementation of 4P medicine.
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